Format

Send to

Choose Destination
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1428-1433. doi: 10.1016/j.bbrc.2018.07.059. Epub 2018 Jul 13.

Salusin-β mediate neuroprotective effects for Parkinson's disease.

Author information

1
Laboratory of Stem Cells and Cell Reprogramming, Department of Biomedical Engineering (BK21 plus), Dongguk University, 30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea.
2
Acupuncture and Meridian Science Research Center, Department of Korean Medical Science, Graduate School of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea. Electronic address: acufind@khu.ac.kr.
3
Department of Biomedical Sciences, Center for Creative Biomedical Scientists, Chonnam National University, Gwangju, 61469, Republic of Korea. Electronic address: jsong0304@chonnam.ac.kr.
4
Laboratory of Stem Cells and Cell Reprogramming, Department of Biomedical Engineering (BK21 plus), Dongguk University, 30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea; Department of Chemistry, Dongguk University, 30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea. Electronic address: jpkim153@dongguk.edu.

Abstract

Neuropeptides, small peptides found in many mammalian brain, play key roles in communicating with each other to modulate neuronal activity. Here, we reported that endogenous neuropeptide salusin-β has neuroprotective effects on the midbrain dopamine neurons and can be used as an effective therapeutic treatment for Parkinson's disease (PD). We found that the MrgprA1 receptor mediates the neuroprotective effects of salusin-β on the midbrain dopamine neurons. Importantly, intranasal administration of salusin-β in a PD mouse model show the neuroprotection of dopaminergic neurons and increased the survival of midbrain dopamine neurons. Furthermore, inhibition of the salusin-β receptor, MrgprA1, abolished the neuroprotective effects induced by salusin-β. Taken together, these results demonstrate the novel role of salusin-β in the central nervous system and salusin-β can be used as a novel therapeutic to effectively treat PD.

KEYWORDS:

Neuropeptide; Neuroprotective effect; Parkinson's disease; Salusin-β

PMID:
30017195
DOI:
10.1016/j.bbrc.2018.07.059
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center